» Articles » PMID: 29203060

Prevalence of Metabolic Syndrome in Middle-East Countries: Meta-analysis of Cross-sectional Studies

Overview
Specialty Endocrinology
Date 2017 Dec 6
PMID 29203060
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Metabolic syndrome is an important metabolic disorder which impose noticeable burden on health system. We aimed to review and imply the prevalence of it in Middle-East countries.

Methods: present study was a systematic review to present overview about metabolic disorder in Middle East. Electronic literature search of Medline database and Google scholar were done for English-language articles without time filtering, as well as for population-based or national studies of the prevalence of metabolic syndrome. The fallowing search terms were used simultaneously: prevalence of metabolic syndrome" and "national study", "prevalence of metabolic syndrome in Middle East", "prevalence of metabolic syndrome" and "name of country", "metabolic syndrome &name of country". Additionally, relevant articles in bibliography were searched. Analysis of data was carried out in STATA version 11.0.

Results: out of 456 studies in first-step searching (selecting by title) 59 studies were recruited and reviewed. Prevalence of metabolic syndrome fluctuated by country and time of study. This amount was 2.2-44% in Turkish, 16-41% in Saudi-Arabia, 14-63 in Pakistan, 26-33 in Qatar, 9-36 in Kuwait, 22-50 in Emirate, 6-42 in Iran, and up to 23 in Yemen. Pooled estimate was 25%. Attributable risk for cardiovascular disease, coronary heart disease, and stroke was 15.87, 11.7, and 16.23, respectively.

Conclusion: The prevalence rate of metabolic syndrome is high and it is noticeable cause for stroke, coronary heart disease, and cardiovascular disease.

Citing Articles

Prevalence of Metabolic Syndrome Among Adults Aged 50 and Above and Associated Factors: A Cross-Sectional Study From Ardakan Cohort Study on Aging (ACSA).

Hooshmand E, Akbarzade I, Delbari D, Niroomand M, Ghavidel F, Saatchi M Health Sci Rep. 2025; 8(3):e70508.

PMID: 40046099 PMC: 11879886. DOI: 10.1002/hsr2.70508.


The impact of urolithiasis on urology services in a high-prevalence region: A multicenter study.

Kamal W, Alghamdi M, Azhar R, Bugis A, Abuzenada M, Alharthi M Asian J Urol. 2025; 12(1):59-65.

PMID: 39990065 PMC: 11840314. DOI: 10.1016/j.ajur.2024.04.001.


Accuracy of the Modified Finnish Diabetes Risk Score (Modified FINDRISC) for detecting metabolic syndrome: Findings from the Indonesian national health survey.

Cahyaningsih I, Rokhman M, Sudikno , Postma M, van der Schans J PLoS One. 2025; 20(2):e0314824.

PMID: 39937716 PMC: 11819590. DOI: 10.1371/journal.pone.0314824.


Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank.

Alsheikh R, Aldulaimi H, Hinawi R, Al-Sadi F, Al-Baker A, Alkuwari A Nutr Metab (Lond). 2025; 22(1):8.

PMID: 39885554 PMC: 11783880. DOI: 10.1186/s12986-024-00892-y.


Associations Between Delayed Sleep Phase Syndrome and Daytime Napping with the Metabolic Syndrome Among Adults: Results from the Ravansar Non-Communicable Disease (RaNCD) Cohort Study.

Hemati N, Alipouriani A, Moradinazar M, Ahmadi A, Mohammadi R, Bonyani M Alpha Psychiatry. 2025; 25(6):705-712.

PMID: 39830049 PMC: 11739914. DOI: 10.5152/alphapsychiatry.2024.241565.